CASE STUDY OF PLEOMORPHIC RHABDOMYOSARCOMA IN PATIENT WITH NEUROFIBROMATOSIS TYPE-1

Authors

  • Abu baker Khan Khyber Medical College, Peshawar
  • Aftab Ahmed Khyber Medical College, Peshawar
  • Ilyas Muhammad Khyber Medical College, Peshawar

Abstract

Background A 42-year-old man, known case of neurofibromatosis type 1 with café au late spots on trunk and extremities, neurofibromas, axillary freckling, pseudoarthrosis of distal tibia. He presented to the district cancer hospital with complaint of huge mass on lateral chest wall. Incisional biopsy was done and case was diagnosed with pleomorphic rhabdomyosarcoma. Immune/histochemical staining is positive for desmin. Rhabdomyosarcoma is a malignant soft tissue tumour with rare incidence in general population. There are few cases of pleomorphic rhabdomyosarcoma in NF 1 patient are reported in literature. This case study reports a rare occurrence of rhabdomyosarcoma in adult neurofibromatosis 1 patient. 

Author Biographies

Abu baker Khan, Khyber Medical College, Peshawar

Ophthalmology, Hayatabad Medical ComplexHouse Officer

Aftab Ahmed, Khyber Medical College, Peshawar

Gyne/obs, Hayatabad Medical ComplexHouse Officer

Ilyas Muhammad, Khyber Medical College, Peshawar

Surgery, Hayatabad Medical ComplexHouse Officer

References

Rad E, Dodd K, Thomas L, Upadhyaya M, Tee A. STAT3 and HIF1α signaling drives oncogenic cellular phenotypes in malignant peripheral nerve sheath tumors. Mol Cancer Res 2015;13(7):1149–60.

Yap YS, McPherson JR, Ong CK, Rozen SG, Teh BT, Lee AS, et al. The NF1 gene revisited–from bench to bedside. Oncotarget 2014;5(15):5873–92.

Wang LH, Wu CF, Rajasekaran N, Shin YK. Loss of tumor suppressor gene function in human cancer: An overview. Cell Physiol Biochem 2018;51(6):2647–93.

Ruggieri M. Different forms of neurofibromatosis. Childs Nerv Syst 1999;15(6-7):295–308.

National Institutes of Health. National Institutes of Health Consensus Development Conference: magnetic resonance imaging. JAMA 1988;259(14):2132–8.

Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44(2):81–8.

Korf BR. Diagnostic outcome in children with multiple café au lait spots. Pediatrics 1992;90(6):924–7.

Wu J, Patmore DM, Jousma E, Eaves DW, Breving K, Patel AV, et al. EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors. Oncogene 2014;33(2):173–80.

Poyhonen M, Niemela S, Herva R. Risk of malignancy and death in neurofibromatosis. Arch Pathol Lab Med 1997;121(2):139–43.

Oguzkan S, Terzi YK, Güler E, Derbent M, Agras PI, Saatci U, et al. Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene. Cancer Genet Cytogenet 2006;164(2):159–63.

Crucis A, Richer W, Brugières L, Bergeron C, Marie‐Cardine A, Stephan JL, et al. Rhabdomyosarcomas in children with neurofibromatosis type I: a national historical cohort. Pediatr Blood Cancer 2015;62(10):1733–8.

Demiralp B, Ozdemir MT, Erler K, Basbozkurt M. Type 1 neurofibromatosis and adult extremity sarcoma A report of two cases. Acta Orthop Belg 2007;73(3):403–7.

Joy T, Tupkari JV, Hanchate AV, Siwach P. Oral rhabdomyosarcoma in an adult male: A rare case report. J Oral Maxillofac Pathol 2018;22(2):285.

Published

2021-11-08